Skip to main content
Research

Publications: MRS Katila George

Dobson R ( 2023 ) . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis . Multiple Sclerosis Journal
Dobson R ( 2023 ) . Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination . Multiple Sclerosis Journal
Jacobs BM, Schalk L, Dunne A, Scalfari A, Nandoskar A, Gran B, Mein CA, Sellers C et al. ( 2023 ) . ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK . BMJ Open vol. 13 , ( 5 )
Tallantyre E, Vickaryous N, Richards A, Rios F, George K, Scurr M, Loveless S ( 2022 ) . T-cell response following COVID booster vaccination in seronegative people with multiple sclerosis . Journal of Neurology Neurosurgery & Psychiatry . vol. 93 ,
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. ( 2022 ) . Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis . Multiple Sclerosis and Related Disorders vol. 64 ,
Dobson R ( 2022 ) . Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS) . Multiple Sclerosis and Related Disorders
Dobson R, Baker D, Kang A, Schmierer K, Giovannoni G ( 2021 ) . COVID-19 vaccine response in people with multiple sclerosis . Annals of Neurology
Dobson R, Holden D, Vickaryous N, Bestwick J, George K, Sayali T, Bianchi L, Wafa M et al. . A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis .
Tallantyre EC, Vickaryous N, Anderson V, Asardag AN, Baker D, Bestwick J, Bramhall K, Chance R et al. . COVID-19 vaccine response in people with multiple sclerosis .
Jacobs BM, Schalk L, Tregaskis-Daniels E, Scalfari A, Nandoskar A, Dunne A, Gran B, Mein CA et al. . Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgrounds .
Tallantyre EC, Scurr MJ, Vickaryous N, Richards A, Anderson V, Baker D, Chance R, Evangelou N et al. . Response to COVID-19 booster vaccinations in seronegative people with MS .